Category: Health

Categories
Health

‘Dying Doulas’ Present Help on the Finish of Life

‘Death Doulas’ Provide Aid at the End of Life

Since its inception in 2018, the National End-of-Life Doula Alliance, a professional organization of practitioners and trainers in the end of life, has grown to nearly 800 members; The number of members has almost doubled in the last year, said its President Angela Shook. There has been increased interest in training programs with the International End-of-Life Doula Association, Doulagivers, and the Doula Program to Accompany and Comfort, a nonprofit led by hospice social worker Amy L. Levine.

Much of the growing interest in these programs has come from artists, actors, youth and restaurant workers who were unemployed during the pandemic and realized they could still be of use.

“People of different ages, younger than we would normally see, because they realized that people in their age group were dying, which they usually don’t,” said Diane Button, 62, of San Francisco, a Doula Facilitator at UVM and a member the Bay Area End-of-Life Doula Alliance, a collective of death workers. “It made them more aware of their own mortality and really got them to plan and get their documents and living wills in order.”

Rebecca Ryskalczyk, 32, singer in Vergennes, Vt., Had always felt “pretty good” in death. When she was 12, she lost two cousins ​​in a plane crash and four years later a friend to suicide. When Covid paused her performance schedule, she enrolled with UVM. Its aim is to convey to people that they do not have to be afraid of death; you don’t have to do it alone either. “To be able to stand up for someone and share the last moments of their life with them and help them stick to their plan when they may not be able to express it is an honor,” she said.

Kate Primeau, 35, was also in the music industry before the pandemic. Last June, after her grandfather died of Covid-19, she began researching how to host a Zoom memorial and came across the concept of a death doula. “I felt a huge gap between the amount of grief everyone felt and the resources available,” she said. She was certified as an end-of-life doula by Alua Arthur’s company Going with Grace and is also volunteering in a hospice program. “I can’t believe how much I laugh at all this death education.”

Of course, during the pandemic, doulas had to change the way they work. That was one of the biggest challenges: you couldn’t interact in person. So, like the rest of the world, they used Zoom calls and FaceTime. Families often sought their own healing.

Categories
Health

Covid is deadlier this 12 months than all of 2020. Why do People assume it is over?

Covid is deadlier this year than all of 2020. Why do Americans think it's over?

Fans in the audience react as The Foo Fighters reopen Madison Square Garden in New York City on June 20, 2021.

Kevin Mazur | Getty Images

As the US presses on its reopening, easing masking requirements and lifting public health restrictions, much of the rest of the world is experiencing an alarming spike in Covid-19 infections and deaths.

The stark contrast underscores how unevenly the coronavirus pandemic has spread and is now hitting low-income countries harder as they struggle with access to vaccines, the rapid spread of new variants, and heavily stressed health systems.

It also shows why the global health crisis is far from over, even if nations like the US, China and the UK are seeing relatively low levels of Covid-19 infections and deaths thanks to a mass vaccination campaign.

According to the World Health Organization, more people died of Covid-19 this year than in all of 2020. The official worldwide death toll was 1,813,188 at the end of 2020. More than 2 million people have died as a result of Covid so far this year.

Covid-19 cases in the US have fallen well below the winter peak in recent weeks, with new diagnoses now falling a seven-day average of around 11,310 per day, compared to more than 250,000 at the start of the year. Fewer reported infections were associated with fewer hospitalizations and fewer deaths.

It has paved the way for most states to pursue plans to return to business as usual, with California and New York lifting most of their public health restrictions in the past few days.

California Governor Gavin Newsom said the state “turned the page on this pandemic,” while New York Governor Andrew Cuomo said, “We don’t just survive – we thrive.”

Fans break out after Phoenix Suns striker Mikal Bridges (25) shot a three-pointer over LA Clippers guard Reggie Jackson (1) late in the first game of the NBA Western Conference Finals at the Phoenix Suns Arena.

Robert Gauthier | Los Angeles Times | Getty Images

Mississippi and Texas both lifted all Covid restrictions in March, with Texas Governor Greg Abbott adding additional threats of fines in May for cities and local officials who still impose mask requirements.

In the US, amusement parks, sports stadiums and bars are reopening and operating at full capacity since the Centers for Disease Control and Prevention eased their mask guidelines in May. The country’s leading health agency said it was safe for fully vaccinated people to take off their masks whether they were outside or inside.

“Two-lane pandemic”

The latest Axios-Ipsos Coronavirus Index found that the country’s fears of Covid-19 continued to decline as people increasingly got out of their homes. In the week ending June 8, about two-thirds of Americans saw family and friends, and 61% went to eat.

Both numbers have risen since the end of May and are said to represent “the highest level of out-of-home activities since the beginning of the pandemic”. The Axios-Ipsos survey was conducted from June 4th to 7th and was based on a nationally representative probability sample of 1,027 adults.

The return to normal in the US was encouraged by the country’s relatively high vaccination rates. More than 177 million doses have been given in the US, which according to US data, 53% of the population gives at least one dose. In contrast, some of the poorest countries in the world still have to register a single dose.

White House Health Advisor Dr. Anthony Fauci, during a press conference on the pandemic Tuesday, said the highly transmissible Delta variant is the “greatest threat” to the nation’s attempt to eradicate Covid-19.

Delta, which was first identified in India, now accounts for about 20% of all new cases in the United States, up from 10% about two weeks ago, Fauci said. He previously warned the country should not fall into the trap of believing the coronavirus crisis is over and no longer needs to be addressed.

In the global battle for Covid-19 vaccines, high-income countries have, as predictably, first tried to secure supplies for their own populations. It has created a situation where millions of people in countries like the US, UK and China have been given doses, largely thanks to domestic vaccine development and through pre-purchase agreements with manufacturers.

In comparison, parts of Africa, Asia and the Pacific islands have so far had low vaccination rates. Less affluent countries rely on Covax, the WHO vaccine exchange initiative. Vaccine diplomacy has also played an important role in the race for security of supply, despite health professionals raising questions about the effectiveness of vaccines made in China.

Ireland’s Health Minister Stephen Donnelly appeared to have gotten to the heart of why high-income countries are taking a “first-person” approach to vaccines when he spoke to the country’s Newstalk radio station earlier this year.

The idea that countries would be willing to vaccinate other countries before vaccinating their own populations “obviously doesn’t hold up,” Donnelly said. Referring specifically to the UK, he added, “You are not doing it. We would not be doing it.”

Tedros Adhanom Ghebreyesus, Director General of the World Health Organization (WHO), speaks after Dr. Anthony Fauci, Director of the National Institute for Allergies and Infectious Diseases, during the 148th session of the Executive Board on the Coronavirus Disease (COVID-19) outbreak in Geneva, Switzerland, January 21, 2021.

Christopher Black | WHO | via Reuters

WHO Director General Tedros Adhanom Ghebreyesus has described persistent global inequality as “vaccine apartheid” and a “catastrophic moral failure” that has led to a “two-pronged pandemic”.

The WHO has warned that Covid-19 is spreading faster than the global distribution of vaccines. The common goal of the world must be to vaccinate at least 70% of the world’s population by the next meeting of the G-7 in Germany next year. Tedros has announced that it will take 11 billion doses of vaccine to meet this goal.

The heads of state and government of the G-7 promised on June 11 that they would secure an additional 1 billion vaccine doses either directly or through Covax over the next 12 months.

“This is a big help, but we need more and we need it faster. More than 10,000 people die every day,” Tedros said at a press conference on June 14th.

“These communities need vaccines now, not next year,” he added.

Access to the vaccine

Health experts have warned billions of people worldwide may not have access to vaccines this year, a prospect that increases the risk of further mutations in the virus – potentially undermining the effectiveness of existing vaccines – and prolong the pandemic.

“The very unequal access to vaccines between rich and poor countries is probably the most glaring example of how global inequalities manifest themselves during the Covid-19 pandemic,” says Dr. Michael Baker, an epidemiologist at the University of Otago in Wellington, New Zealand told CNBC.

Many groups have urged the waiver of certain intellectual property rights in Covid-19 vaccines and treatments, including the WHO, health experts, former world leaders and international medical charities.

President Joe Biden’s administration has thrown its weight behind the demands, but a small number of governments – including the UK, the EU and Brazil – have blocked a groundbreaking proposal submitted to the World Trade Organization.

A Personal Protective Equipment (PPE) officer manages the crowd while people line up in Phnom Penh on May 31, 2021 as part of the government’s campaign to curb the rising number of cases of China’s Sinopharm Covid-19 coronavirus Get vaccine.

TANG CHHIN SOTHY | AFP | Getty Images

The latest WHO figures show that the number of new cases has fallen worldwide for eight straight weeks, but that trend obscures worrying increases in cases and deaths in many countries.

“The decline has slowed in most regions, and in every region there are countries that are seeing rapid increases in cases and deaths. In Africa, the number of cases and deaths rose by almost 40% in the past week, and in some countries the number of deaths has tripled or quadrupled, “Tedros said at a briefing on Monday.

A study published May 22 in the medical journal The Lancet found that Africa has the world’s highest mortality rate among seriously ill Covid-19 patients, although fewer cases are recorded than most other regions.

“While a handful of countries have high vaccination rates and are now experiencing fewer hospital admissions and fewer deaths, other countries in Africa, America and Asia are now facing severe epidemics. These cases and deaths are largely preventable, ”said Tedros.

Warning delta variant

Health professionals are concerned about the spread of the highly transmissible Delta variant. The Covid variant first identified in India is believed to be well on the way to becoming the dominant strain of the disease worldwide.

Former FDA commissioner Dr. Scott Gottlieb told CNBC Thursday that the spread of the Delta variant in the US was “very worrying,” noting that its prevalence in the country is currently doubling every 10 to 14 days.

“It will become the dominant strain in the United States. Now the question is, will it be 90% of 10,000 infections a day or 90% of 100,000 infections a day?” said Gottlieb.

“I think as far as the summer is concerned, even with this new variant, we probably won’t see a major flare-up of infections, but this is a significant risk for the fall,” said Gottlieb.

Categories
Health

Scientist Finds Early Coronavirus Sequences That Had Been Mysteriously Deleted

Scientist Finds Early Coronavirus Sequences That Had Been Mysteriously Deleted

“These additional data will play a big role in that effort,” Dr. Worobey said.

It’s not clear why this valuable information went missing in the first place. Scientists can request that files be deleted by sending an email to the managers of the Sequence Read Archive. The National Library of Medicine, which manages the archive, said that the 13 sequences were removed last summer.

“These SARS-CoV-2 sequences were submitted for posting in SRA in March 2020 and subsequently requested to be withdrawn by the submitting investigator in June 2020,” said Renate Myles, a spokeswoman for the National Institutes of Health.

She said that the investigator, whom she did not name, told the archive managers that the sequences were being updated and would be added to a different database. But Dr. Bloom has searched every database he knows of, and has yet to find them. “Obviously I can’t rule out that the sequences are on some other database or web page somewhere, but I have not been able to find them any of the obvious places I’ve looked,” he said.

Three of the co-authors of the 2020 testing study that produced the 13 sequences did not immediately respond to emails inquiring about Dr. Bloom’s finding. That study did not give contact information for another co-author, Dr. Fu, who was also named on the spreadsheet from the other study.

Some scientists are skeptical that there is anything sinister behind the removal of the sequences. “I don’t really understand how this points to a cover-up,” said Stephen Goldstein, a virologist at the University of Utah.

Dr. Goldstein noted that the testing paper listed the individual mutations the Wuhan researchers found in their tests. Although the full sequences are no longer in the archive, the key information has been public for over a year, he said. It was just tucked away in a format that is hard for researchers to find.

“We all missed this relatively obscure paper,” Dr. Goldstein said.

“You can’t really say why they were removed,” Dr. Bloom acknowledged in an interview. “You can say that the practical consequence of removing them was that people didn’t notice they existed.” He also noted that the Chinese government ordered the destruction of a number of early samples of the virus and barred the publication of papers on the coronavirus without its approval.

Categories
Health

CDC group says there is not sufficient information but to suggest booster pictures

CDC group says there isn't enough data yet to recommend booster shots

A group of Centers for Disease Control and Prevention scientists said Wednesday that currently there isn’t enough data to support recommending Covid-19 booster shots to the general population but that more-vulnerable groups, such as elderly people or transplant recipients, may need an extra dose.

The Covid-19 working group of the CDC’s Advisory Committee on Immunization Practices didn’t rule out the possibility that the general population eventually may need booster shots if immunity from the vaccines wanes or a variant reduces the effectiveness of current shots.

“Boosters may be required for a broad population. However, it could also be that the need for boosters of Covid vaccine may only be demonstrated in some populations,” said Dr. Sarah Oliver, co-lead of the working group and a medical epidemiologist with the CDC’s National Center for Immunization and Respiratory Diseases.

A recent study by researchers at Johns Hopkins University published in the Annals of Internal Medicine showed that booster shots may be beneficial for people with weakened immune systems. Oliver said the agency should monitor residents of long-term care facilities, elderly people, health-care workers and immunocompromised people.

The working group recommended that the CDC consider booster shots only “after evidence of declining protection,” Oliver said, meaning if the vaccines became less effective over time or antibodies guarding against Covid waned over time. The agency could also consider using booster shots if a variant emerged that substantially reduced the effectiveness of the vaccine.

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.

Dado Ruvic | Reuters

“I would have to agree with the interpretation of the working group in the sense that there’s no data to support recommendations to support boosters at this time,” said Dr. Sharon Frey, a member of ACIP and clinical director of the Center for Vaccine Development at Saint Louis University Medical School. “There’s no evidence against declining protection at this time.”

But Frey said she would be open to giving a third shot to transplant patients or if infections rise in the general population, indicating a lot of breakthrough cases in fully vaccinated individuals. So far, there have been at least 3,729 breakthrough infections in the U.S. that resulted in hospitalization or death, according to CDC data.

“I think the only thing we can do at this moment is, if we start to see an uptick in reinfection in people or new infections in people who have been vaccinated, that’s our clue that we need to move quickly,” Frey said.

Dr. Grace Lee, who chairs the ACIP safety group and is a professor of pediatrics at Stanford University School of Medicine, also said she would like to see more evidence of breakthrough cases before recommending a booster shot.

“I would want greater certainty on the safety data if we’re talking about boosting before it’s clear what the risk data will look like,” Lee said. “If we’re seeing severe breakthrough cases then I think the decision-making moves forward even if there’s uncertainty with the safety data.”

Categories
Health

Coronary heart Issues After Vaccination Are Very Uncommon, Federal Researchers Say

Heart Problems After Vaccination Are Very Rare, Federal Researchers Say

The coronavirus vaccines manufactured by Pfizer-BioNTech and Moderna could have caused heart problems in more than 1,200 Americans, including about 500 who were under 30, according to data reported Wednesday by researchers at the Centers for Disease Control and Prevention .

Still, the benefits of vaccination far outweighed the risks, and CDC advisors strongly recommended vaccination for all Americans 12 and older.

The reported heart problems are myocarditis, which is inflammation of the heart muscle; and pericarditis, inflammation of the lining of the heart. The risk is higher after the second dose of an mRNA vaccine than after the first, the researchers reported and much higher in men than in women.

Overall, however, the side effect is very rare – only 12.6 cases per million second doses given. The researchers estimated that out of a million second doses given to boys ages 12-17, the vaccines could cause a maximum of 70 cases of myocarditis, but would prevent 5,700 infections, 2,215 hospitalizations, and two deaths.

Agency researchers presented the data to members of the Advisory Committee on Immunization Practices, which makes recommendations on vaccine use in the United States. (The scientists grouped pericarditis with myocarditis for reporting purposes.)

Most of the cases were mild, with symptoms like fatigue, chest pain, and irregular heartbeat that cleared up quickly, the researchers said. Of the 484 cases reported in Americans under the age of 30, the CDC has definitely linked 323 cases to vaccination. The rest are still being investigated.

“These events are really very rare, extremely rare,” said Dr. Brian Feingold, an expert on pediatric heart inflammation at UPMC Children’s Hospital in Pittsburgh. “That has to be seen in the context of illness and morbidity and mortality in connection with Covid.”

Separately, more than a dozen state and professional medical organizations said in a joint statement Wednesday that myocarditis “is an extremely rare side effect and affects an extremely small number of people after vaccination.”

Federal researchers also presented early safety data on Wednesday on the six million vaccine doses given to children ages 12 to 15. The side effects – usually fatigue and pain at the injection site – were similar to those seen in young people aged 16-25.

“So far, the Covid-19 vaccines approved in the USA have shown a high level of safety,” said Dr. Matthew F. Daley, Principal Investigator at Kaiser Permanente Colorado and a member of the Advisory Committee.

The CDC advisors met when the Biden administration publicly admitted that it expects to miss its target of at least partially vaccinating 70 percent of Americans by July 4, will be immunized.

About two in 100,000 people aged 15 to 18 – about two-thirds of them male – are hospitalized with myocarditis each year, according to data presented at the meeting. Patients with the most severe cases may need mechanical assistance, such as a ventilator or a heart transplant.

Even people with mild symptoms may have to abstain from exercise for about six months after recovery. It is unclear what typically causes the condition or why it is more common in young men than women.

Updated

June 23, 2021 at 4:46 p.m. ET

The first cases of coronavirus vaccine-related myocarditis were reported in Israel, mostly in young men ages 16-19. Israel recorded 148 cases, 95 percent of them mild, from December to May.

In the United States, too, myocarditis was more common in men and boys: up to 80 percent of the cases diagnosed after the second dose were in men. There was also a marked difference in age, with the side effect becoming more common in people in their late teens and early 20s.

As of June 21, about 318 million doses of coronavirus vaccine had been administered in the United States and 150 million people are considered fully protected. Most symptoms of myocarditis appeared within about four days of the first or second dose.

“We have clear evidence here that vaccinated cases started within the first week,” said Dr. Tom Shimabukuro, a vaccine expert at the CDC, who presented the new data. There is also a dose effect, he said, adding, “The rates are higher with both vaccines after the second dose.”

The vast majority of patients with the side effect made a full recovery, noted Dr. James de Lemos, a cardiologist at the University of Texas Southwestern Medical Center at Dallas, who reported one of the first cases in January.

Covid-19 itself can cause heart problems in young people. A large study of college athletes showed that 2.3 percent of those who recovered from Covid-19 had heart abnormalities associated with myocarditis.

“Even in young men, myocarditis will be far more common if you get Covid than if you get a vaccine,” said Dr. de Lemos.

More than 4,000 children infected with the coronavirus developed a multisystem inflammatory syndrome that includes cardiac symptoms. Some children have also died while none died from the vaccination, noted Dr. Fine gold. “You can say no to the vaccine, but you take different risks.”

The CDC recommends vaccination for all Americans over the age of 12. But on Wednesday officials suggested that anyone who develops myocarditis after the first dose should postpone a second dose until they discuss the risks with a doctor.

The CDC’s recommendations may influence decisions about whether to vaccinate children under 12 years of age when vaccines become available for that age group. Some experts have questioned whether the benefits to children outweigh the potential risks, as the chances of developing serious illness from the virus in young children are small.

Still, the agency reported this month that Covid-19-related hospitalizations among teenagers in the United States were about three times higher than influenza-related hospitalizations in the last three flu seasons.

The total number of infections has fallen sharply since January, but as more adults have been vaccinated, the proportion of children in the total has increased. About a third of the new infections reported in May were in Americans ages 12 to 29, and there have been 316 deaths in that age group since April.

Vaccination becomes an even more pressing priority given more contagious variants of the coronavirus now circulating in the United States, said Dr. Paul Offit, a member of the Food and Drug Administration’s Vaccination Safety Committee, in an interview.

“We’re still a long way from where we need to be” in terms of the percentage of Americans who should be vaccinated, said Dr. Offit, who is also a pediatrician at the Philadelphia Children’s Hospital. “And you will go into winter when you have a generally underinoculated population.”

Categories
Health

CDC says there’s seemingly hyperlink between uncommon coronary heart irritation in younger folks after Covid shot

CDC says there's likely link between rare heart inflammation in young people after Covid shot

A CDC safety group said there was a “likely link” between rare heart inflammation in adolescents and young adults, mostly after they received their second Covid-19 vaccine, citing the latest available data.

There have been more than 1,200 cases of myocarditis or pericarditis, mostly in those under 30 who have the Covid- Vaccine received from Pfizer or Moderna have practices methods exercises.

Myocarditis is the inflammation of the heart muscle while pericarditis is the inflammation of the membrane that surrounds the heart.

“The clinical picture of myocarditis cases after vaccination was variable and most often appeared within a week of the second dose, with chest pain being the most common,” said Dr. Grace Lee, Chair of the Committee’s Security Group. CDC officials are collecting more data to fully understand the potential risks, how to deal with them and if there are any long-term issues, she said.

Zoom In Icon Arrows pointing outwards

The agency said 267 cases of myocarditis or pericarditis were reported after receiving one dose of the mRNA vaccines and 827 cases after two doses by June 11. There are 132 additional cases where the number of doses received is unknown, the CDC said.

The agency announced that around 300 million shots had been administered by June 11.

“This is still a rare occurrence,” said Dr. Tom Shimabukuro at the meeting. For both vaccines combined, there were 12.6 cases of heart inflammation per million doses. Cases were more common among Moderna vaccine recipients at 19.8 cases per million than eight cases per million at Pfizer, he said.

Men under 30 make up the bulk of cases, the CDC said, and most cases appear to be mild. Of the 295 people who developed the disease and were discharged, 79% made a full recovery, according to the presentation. Nine people were hospitalized, according to the agency, two of them in the intensive care unit.

CDC officials said the benefits of the Covid vaccine still outweigh the risks.

Cases in younger people are increasing as older people are vaccinated at higher rates. The US vaccinated 177.6 million people with at least one dose, according to the CDC, that’s about 53% of the population. Only 13.6% of 18- to 24-year-olds in the United States received at least one dose of vaccine, compared with 26% of people ages 50 to 64, the data shows.

While hospitalization rates have decreased in older age groups, they have barely moved in adolescents and young adults, said Dr. Megan Wallace from the CDC.

“Teenagers and young adults make up a larger proportion of the total cases, 33% of the cases reported in May were people ages 12-29, compared with 28% last December,” she said. Since the pandemic began, 2,767 people aged 12 to 29 have died of Covid, she said, noting that 316 of these deaths had occurred since April 1.

The CDC is coordinating its investigation with the Food and Drug Administration, which last month approved the Pfizer BioNTech vaccine for adolescents ages 12-15. Symptoms like chest pain and shortness of breath usually develop within a week of receiving the vaccination, with most developing within four days, the agency said.

This is a developing story. Please check again for updates.

CNBC’s Rich Mendez contributed to this article.

Correction: Most of the cases of people who had myocarditis occurred in people under the age of 30. In a previous version, the age was incorrectly stated. The number of cases per million doses administered was 12.6. In an earlier version, the number was incorrectly specified.

Categories
Health

C.D.C. Advisers to Focus on Uncommon Coronary heart Issues in Vaccinated Youth

C.D.C. advisers are expected to discuss rare heart problems in vaccinated younger people.

Advisors to the Centers for Disease Control and Prevention will meet on Wednesday to address reports of rare heart problems in young people immunized with Pfizer-BioNTech and Moderna’s coronavirus vaccines.

The reports pertain to conditions called myocarditis, inflammation of the heart muscle; and pericarditis, inflammation of the membrane surrounding the heart. Most of the cases were mild, with symptoms such as fatigue, chest pain, and irregular heartbeat that go away quickly. The agency is tracking nearly 800 reports, although not all of them have definitely been linked to the vaccines.

The CDC advisors meeting comes as the Biden administration publicly recognizes it expects to miss its goal of partially immunizing 70 percent of Americans by July 4th.

Experts have said that the benefits of vaccination far outweigh the risk of potential problems, but they are expected to revisit this debate, especially for adolescents and young adults.

More than half of heart problems were reported in Americans ages 12 to 24, while that age group accounted for only 9 percent of the millions of doses given. The numbers are higher than one would expect for this age.

As of May 31, 216 people had developed myocarditis or pericarditis after a dose of either vaccine and 573 after the second dose. While most of the cases were mild, 15 patients remained in hospitals at this point. The second dose of Pfizer BioNTech vaccine was associated with approximately twice as many cases as the second dose of Moderna’s vaccine.

“We look forward to more clarity about the potential risk of myocarditis after mRNA vaccines in order to increase vaccination confidence and rates,” said Dr. Yvonne Maldonado, Chair of the Committee on Infectious Diseases at the American Academy of Pediatrics.

Recommendations from CDC advisors after Wednesday’s meeting may also influence decisions about immunizing children under 12 if vaccines are available for that age group. Some experts have questioned whether the benefits to children outweigh the potential risks given the low likelihood of serious illness in young children.

The CDC strongly recommends Covid-19 vaccines for Americans 12 and older. The agency reported this month that Covid-19-related hospitalizations among teenagers in the United States were about three times higher than influenza-related hospitalizations for the past three flu seasons.

By June 10, according to the American Academy of Pediatrics, nearly 17,000 children in 24 states had been hospitalized for Covid-19 and 330 children had died.

Categories
Health

GSK client enterprise cut up off after investor strain from Elliott Administration

GSK consumer business split off after investor pressure from Elliott Management

View of the headquarters of the British pharmaceutical company GlaxoSmithKline in west London.

Ben Stansall | AFP | Getty Images

LONDON — British pharmaceutical giant GlaxoSmithKline faces a crunch meeting with investors on Wednesday after announcing a new strategy for the next decade centered on the splitting off of the company’s substantial consumer products arm.

The new core drug and vaccine division, which CEO Emma Walmsley has dubbed “New GSK,” has set targets of 5% sales growth and 10% profit growth between now and 2026. The separation is expected to take effect in mid-2022.

GSK is also aiming for more than £33 billion ($46.2 billion) worth of sales by the end of the decade, which it hopes will offset the loss of exclusivity over HIV medication dolutegravir in 2028.

Investors have reacted positively to the plans thus far, with GSK shares up 3% by mid-afternoon trade in Europe.

However, Walmsley will need the backing of investors at the company’s Capital Markets Day, having been under pressure of late from U.S. activist investor Elliott Management. The virtual session begins at 2 p.m. London time on Wednesday.

Walmsley told CNBC’s “Squawk Box Europe” on Wednesday that the separation of the business was a “step change in growth” and the culmination of a four-year transformational plan, aiming to address “perennial underperformance” in the business.

“This growth is all about a quality vaccines and specialty medicines portfolio, and that is really core to the strategy of New GSK, being focused on prevention of disease as well as treatment,” she said.

“It’s about setting out New GSK as a growth company with new ambitions for shareholders, but also our chance to impact positively the health of 2.5 billion people over the next decade.”

The separate consumer health business, comprising brands like Panadol and Sensodyne, will be demerged with “at least 80%” of the value being returned to shareholders, while GSK plans to temporarily hold 20% to be sold at a later stage.

New GSK will cut its dividend to 45 pence per share in 2023, compared to the 80 pence offered by GSK this year, while the new consumer arm will offer 55p.

Categories
Health

C.D.C. advisers are anticipated to debate uncommon coronary heart issues in vaccinated youthful individuals.

C.D.C. advisers are expected to discuss rare heart problems in vaccinated younger people.

Advisors from the Centers for Disease Control and Prevention are due to meet on Wednesday to discuss reports of rare heart problems in young people immunized with Pfizer-BioNTech and Moderna’s coronavirus vaccines.

The reports pertain to conditions called myocarditis, inflammation of the heart muscle; and pericarditis, inflammation of the membrane surrounding the heart. Most of the cases were mild, with symptoms such as fatigue, chest pain, and irregular heartbeat that go away quickly. The agency is tracking nearly 800 reports, although not all of them have definitely been linked to the vaccines.

The CDC advisors meeting comes as the Biden administration publicly recognizes it expects to miss its goal of partially immunizing 70 percent of Americans by July 4th.

Experts have said that the benefits of vaccination far outweigh the risk of potential problems, but they are expected to revisit this debate, especially for adolescents and young adults.

More than half of heart problems were reported in Americans ages 12 to 24, while that age group accounted for only 9 percent of the millions of doses given. The numbers are higher than one would expect for this age.

As of May 31, 216 people had developed myocarditis or pericarditis after a dose of either vaccine and 573 after the second dose. While most of the cases were mild, 15 patients remained in hospitals at this point. The second dose of Pfizer BioNTech vaccine was associated with approximately twice as many cases as the second dose of Moderna’s vaccine.

“We look forward to more clarity about the potential risk of myocarditis after mRNA vaccines in order to increase vaccination confidence and rates,” said Dr. Yvonne Maldonado, Chair of the Committee on Infectious Diseases at the American Academy of Pediatrics.

Recommendations from CDC advisors after Wednesday’s meeting may also influence decisions about immunizing children under 12 if vaccines are available for that age group. Some experts have questioned whether the benefits to children outweigh the potential risks given the low likelihood of serious illness in young children.

The CDC strongly recommends Covid-19 vaccines for Americans 12 and older. The agency reported this month that Covid-19-related hospitalizations among teenagers in the United States were about three times higher than influenza-related hospitalizations for the past three flu seasons.

By June 10, according to the American Academy of Pediatrics, nearly 17,000 children in 24 states had been hospitalized for Covid-19 and 330 children had died.

Categories
Health

5 issues to know earlier than the inventory market opens Tuesday, June 22

Retail earnings and consumer spending

Here are the top news, trends, and analysis investors need to start their trading day:

1. Wall Street looks stable after the comeback rally; GameStop pops

A view of the New York Stock Exchange building on Wall Street in downtown Manhattan in New York City.

Roy Rochlin | Getty Images Entertainment | Getty Images

US stock futures rose modestly on Tuesday, a day after the Dow recovered a large portion of its 3.5% decline from last week due to the shift in the Federal Reserve’s rate hike schedule. The 30-share average rose 586 points, or nearly 1.8%, earlier in the week. The S&P 500 gained 1.4%, within 1% of its record high. The Nasdaq was Monday’s relative underperformer, up 0.8%.

SELINSGROVE, PENNSYLVANIA, UNITED STATES – 01/27/2021: A woman walks past the GameStop store in the Susquehanna Valley Mall. An online group rocketed GameStop (GME) and AMC Entertainment Holdings Inc. (AMC) shares to suppress short sellers.

Photo by Paul Weaver / SOPA Images / LightRocket via Getty Images

GameStop shares rose 9% in the premarket after the video game retailer and Original Meme stock completed a previously announced sale of 5 million common shares that raised more than $ 1.1 billion. GameStop said it will use the proceeds for general corporate purposes, as well as investing in growth initiatives and maintaining a strong balance sheet.

2. Fed Chairman Powell will testify before the House of Representatives

Federal Reserve Chairman Jerome Powell speaks at a virtual press conference in Tiskilwa, Illinois on December 16, 2020.

Daniel Acker | Bloomberg | Getty Images

10-year government bond yields have rebounded since last week’s Fed-driven surge and brief decline to Monday’s February low. The 10-year yield ticked lower on Tuesday to around 1.47%. Fed chair Jerome Powell is going to a House panel this afternoon, and investors will be looking for more clues to policymakers’ rising inflation outlook and clues to two rate hikes in 2023.

In prepared testimony, Powell said the economy was growing but facing ongoing threats from the Covid pandemic. He also noted that inflation has risen noticeably, but the repeated price pressures will be temporary. The Fed has kept short-term lending rates near zero while buying at least $ 120 billion worth of bonds every month.

3. Bitcoin falls again, breaking below the important $ 30,000 level

This illustration from May 19, 2021 shows the virtual currency Bitcoin in front of a stock chart.

Given Ruvic | Reuters

Bitcoin fell more than 8% on Tuesday and was trading below $ 30,000. China’s renewed crackdown on the cryptocurrency industry has wiped nearly $ 300 billion in value from the entire digital currency market since Friday. As Beijing expanded its shutdown of Bitcoin mining operations, China’s central bank urged financial institutions not to offer any services related to crypto activities. Bitcoin is down more than 50% from its all-time high in April near $ 65,000.

4. EU opens antitrust investigation into Google’s advertising unit

A logo outside the Google Store Chelsea in New York, May 28, 2021.

Victor J. Blue | Bloomberg | Getty Images

The European Commission on Tuesday launched a new antitrust investigation into Alphabet’s Google to investigate whether the tech giant prefers its own online display ad technology services. As part of the investigation, the EU executive will assess the restrictions that Google places on the access of advertisers, publishers and other third parties to access data on user identity and behavior. Earlier this month, the French competition authority fined Google $ 262 million for abusing its market power in online advertising.

5. NYC Democrats will vote in Tuesday’s mayoral election

Mayoral candidates Eric Adams (L) and Andrew Yang

Getty Images

New York City Democratic voters go to the polls Tuesday to vote for their party’s mayoral candidate. Eight candidates – including the former presidential candidate Andrew Yang and the alleged top candidate Eric Adams – hope to replace the Democratic mayor Bill de Blasio, who can no longer run due to term restrictions. Tuesday’s Democratic primary, the winner of which is heavily favored against the GOP candidate in the November general election, is the first time the city has used a ranked selection. Voters will list their preferences in order for up to five candidates. Official results are not announced for weeks.

– NBC News contributed to this report. Follow the whole market like a pro on CNBC Pro. Get the latest on the pandemic with coronavirus coverage from CNBC.